SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-020513
Filing Date
2024-02-26
Accepted
2024-02-26 20:38:26
Documents
1
Period of Report
2024-02-23

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6978
  Complete submission text file 0000950170-24-020513.txt   8458
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O REPLIGEN CORPORATION 41 SYON ST. BLDG. SUITE 100 WALTHAM MA 02453
Business Address
Bylund James (Reporting) CIK: 0001849642 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 24681507